Published in Neurol Sci on October 01, 2004
Clinical features of primary brain tumours: a case-control study using electronic primary care records. Br J Gen Pract (2007) 2.05
The dire need for primary care specialization in India: Concerns and challenges. J Family Med Prim Care (2016) 0.91
Thunderclap headache associated with a nonhemorrhagic anaplastic oligodendroglioma. MedGenMed (2007) 0.76
Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology (1999) 2.27
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer (1994) 1.44
HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol Cell Biol (1996) 1.35
Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry (1999) 1.21
Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol (2008) 1.18
Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry (2005) 1.17
Transduction of the SkBr3 breast carcinoma cell line with the HOXB7 gene induces bFGF expression, increases cell proliferation and reduces growth factor dependence. Oncogene (1998) 1.16
Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol (2005) 1.15
Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial. Neurology (2010) 1.15
Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system. Eur J Histochem (2005) 1.10
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord (2000) 1.09
Endothelium and the brain in CNS lupus. Lupus (2003) 1.05
A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma. Br J Cancer (2009) 1.05
Primary glial tumor patients treated by combining cis-platin and etoposide. J Neurooncol (1991) 0.97
Factors, including transforming growth factor beta, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells. Cancer Immunol Immunother (1993) 0.97
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes. Blood (1993) 0.92
Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. Eur Neurol (1994) 0.91
A double blind study on azathioprine efficacy in multiple sclerosis: final report. J Neurol (1993) 0.91
Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients. Cancer Immunol Immunother (1994) 0.91
Corticosteroids protect oligodendrocytes from cytokine-induced cell death. Neuroreport (2000) 0.90
Immunocompetence of human microvascular brain endothelial cells: cytokine regulation of IL-1beta, MCP-1, IL-10, sICAM-1 and sVCAM-1. J Neurol (1998) 0.90
Immunological monitoring of azathioprine treatment in multiple sclerosis patients. J Neurol (1997) 0.89
Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochem Med Metab Biol (1993) 0.89
CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol (2005) 0.89
Temozolomide and cisplatin in the treatment of leptomeningeal metastatic involvement from melanoma: a case report. Neurol Sci (2002) 0.88
Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol (1996) 0.87
Immunoblotting on polyvinyldifluoride improves detection of oligoclonal IgG bands in CSF. Clin Chem (1987) 0.87
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience. J Neurooncol (2011) 0.86
Cryptococcal meningoencephalitis: intrathecal immunological response. J Neurol (1986) 0.85
Typical and atypical forms of paroxysmal choreoathetosis. Dev Med Child Neurol (1989) 0.85
Combined chemotherapy with temozolomide and fotemustine in recurrent glioblastoma patients. J Neurooncol (2011) 0.84
Safety of bevacizumab in patients with malignant gliomas: a systematic review. Neurol Sci (2013) 0.84
Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10. Scand J Immunol (1996) 0.84
Activation of cerebral endothelium is required for mononuclear cell recruitment in a novel in vitro model of brain inflammation. Neuroscience (2005) 0.83
Poor metabolization of n-hexane in Parkinson's disease. J Neurol (2003) 0.83
Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience. J Neurooncol (2006) 0.83
Immunoblotting techniques with picogram sensitivity in cerebrospinal fluid protein detection. Electrophoresis (1989) 0.82
Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report. Neurol Sci (2009) 0.82
Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurol Sci (2008) 0.82
Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin. Cancer Chemother Pharmacol (1999) 0.82
Update on treatment strategies for anaplastic glioma: a review of literature. Neurol Sci (2014) 0.82
Fotemustine combined with procarbazine in recurrent malignant gliomas: a phase I study with evaluation of lymphocyte 06-alkylguanine-DNA alkyltransferase activity. J Neurooncol (2001) 0.81
In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody. Br J Cancer (1995) 0.81
Stressful life events and multiple sclerosis: a retrospective study. Ital J Neurol Sci (1998) 0.81
Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: a case report. Tumori (1997) 0.81
Natural history and postsurgical outcome of syringomyelia. Ital J Neurol Sci (1991) 0.81
Cisplatin and BCNU chemotherapy for anaplastic oligoastrocytomas. J Neurooncol (2000) 0.81
Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatment. Ital J Neurol Sci (1994) 0.80
Neurobrucellosis mimicking multiple sclerosis: a case report. Eur Neurol (1989) 0.80
Progressive myoclonic ataxia with intrathecal immune activation in six patients. Neurol Sci (2007) 0.80
Lymphotoxin gene expression by melanocytes and melanoma cell lines and persistence of unspliced mRNA. FEBS Lett (1993) 0.80
Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment? Ann Neurol (2000) 0.80
Rechallenge with temozolomide in recurrent glioma. Neurol Sci (2011) 0.80
Pharmacologic evaluation of cardiovascular reflex responses in migraine patients: lack of central sympathetic modulation? Funct Neurol (1990) 0.80
Immunological fluctuations during intrathecal immunotherapy in three patients affected by CNS tumours disseminating via CSF. Int J Neurosci (1994) 0.80
Paraneoplastic cerebellar degeneration with anti-CV2/CRMP5 antibodies and prostate adenocarcinoma. Neurol Sci (2015) 0.80
Meningo-cortical calcifying angiomatosis and celiac disease. Clin Neurol Neurosurg (1998) 0.79
Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients. Ital J Neurol Sci (1999) 0.79
An Italian family with Nasu-Hakola disease. J Neurol (2003) 0.79
Efficacy of intratumoral delivery of mitoxantrone in recurrent malignant glial tumours. J Neurooncol (2001) 0.79
Double blind study of intrathecal beta-interferon in multiple sclerosis: clinical and laboratory results. J Neurol Neurosurg Psychiatry (1990) 0.79
Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results. Eur Neurol (1989) 0.79
Racemose neurocysticercosis after chronic meningitis: effect of medical treatment. Clin Neurol Neurosurg (1995) 0.79
Tremor as an early manifestation of systemic lupus erythematosus. Clin Exp Rheumatol (1994) 0.79
Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data. J Neurol (1993) 0.79
Interstitial chemotherapy plus systemic chemotherapy for glioblastoma patients: improved survival in sequential studies. J Neurooncol (1999) 0.79
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization. Cancer Immunol Immunother (2004) 0.79